BIO vs MAC · rev $2.58B vs rev $918.2M
BIO (BIO) versus Macerich Company (MAC) — a side-by-side from cached financials, not a winner call.
BIO (BIO) common stock.
Macerich Company (MAC) is a reit - retail company listed on US.
Latest reported BIO revenue for 2025-12-31 was $2.58B. Net income was $759.9M. Revenue was up 0.7% from 2024-12-31 to 2025-12-31. BIO currently screens at market cap $0.
Latest reported MAC revenue for 2024-12-31 was $918.2M. Net income was -$197.7M. Revenue was up 3.9% from 2023-12-31 to 2024-12-31. MAC currently screens at market cap $4.41B.
BIO currently screens at market cap $0. MAC currently screens at market cap $4.41B.
Not investment advice. Open the BIO and MAC stock pages for the full models.
Not investment advice.